Takahito Kudo

Recent publications · Crossref

5 total works indexed

1. Heterogeneous photocatalyst materials for water splitting

   · 2009 · cited 10,084x

2. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

   · 2020 · cited 6,449x

3. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

   · 2018 · cited 4,661x

4. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

   · 2017 · cited 3,595x

5. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

   · 2017 · cited 3,075x

via Crossref · CC0

Wikidata facts

Image